Back to search
FDAFDA · Food and drugs·Recall number D-0167-2017

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.

Published December 7, 2016 · Recall initiated: October 28, 2016

Summary

FDA records drug Class II recall D-0167-2017, published December 7, 2016 and initiated October 28, 2016. Recalling firm: Nationwide Laboratories, LLC; Status: Terminated; Reported quantity: 6,333,669 tablets; Lot: Lot #: 28161501, Exp 03/17; 28161502, 28161503, Exp 08/17; 28161601, 28161602, Exp 01/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nationwide Laboratories, LLC
Distributor
Nationwide in USA and Puerto Rico
Lot
Lot #: 28161501, Exp 03/17; 28161502, 28161503, Exp 08/17; 28161601, 28161602, Exp 01/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10. recalled?

Yes. FDA published recall D-0167-2017 on December 7, 2016. Reported hazard: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

What should I do if I have this product?

Voluntary: Firm initiated · Letter